Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Immunity

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1074-7613(00)80170-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice.

  1999cited by this paper
• Osteoblastic Responses to TGF-β during Bone Remodeling

  1998cited by this paper
• REGULATION OF IMMUNE RESPONSES BY TGF-β*

  1998cited by this paper
• Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development

  1998cited by this paper
• TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling*

  1997cited by this paper
• Self-reactive B Cells Are Not Eliminated or Inactivated by Autoantigen Expressed on Thyroid Epithelial Cells

  1997cited by this paper
• TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.

  1997cited by this paper
• Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor β Receptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen 7,12-Dimethylbenz-[a]-anthracene

  1997cited by this paper
• TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

  1997cited by this paper
• Binding Affinity of Transforming Growth Factor-β for Its Type II Receptor Is Determined by the C-terminal Region of the Molecule*

  1996cited by this paper
• Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse.

  1996cited by this paper
• Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.

  1996cited by this paper
• The Liver in Transforming Growth Factor-Beta-1 (TGF-β1) Null Mutant Mice

  1996cited by this paper
• Transforming growth factor–β3 is required for secondary palate fusion

  1995cited by this paper
• Novel in vitro model for high-rate IgA class switching.

  1995cited by this paper
• Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction

  1995cited by this paper
• TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.

  1995cited by this paper
• Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.

  1995cited by this paper
• Analysis of Hornozygous TGFβ1 Null Mouse Embryos Demonstrates Defects in Yolk Sac. Vasculogenesis and Hematopoiesis

  1995cited by this paper
• Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.

  1995cited by this paper
• Mechanism of activation of the TGF-β receptor

  1994cited by this paper
• Immune dysregulation in TGF-beta 1-deficient mice.

  1994cited by this paper
• Receptors for transforming growth factor-beta.

  1994cited by this paper
• A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.

  1994cited by this paper
• Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region

  1993cited by this paper
• Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.

  1993cited by this paper
• Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

  1993cited by this paper
• Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

  1993cited by this paper
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

  1992cited by this paper
• Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.

  1991cited by this paper
• Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo.

  1991cited by this paper
• Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis.

  1991cited by this paper
• Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen.

  1991cited by this paper
• Transforming growth factor beta 1 increases IgA isotype switching at the clonal level.

  1990cited by this paper
• Peptide Growth Factors and Their Receptors I

  1990cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Expression of transforming growth factor beta 2 RNA during murine embryogenesis.

  1989cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice.

  1978cited by this paper

• TGF-β in hematologic malignancies: molecular functions and clinical applications

  2026cites this paper
• CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer

  2026cites this paper
• Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit

  2026cites this paper
• An Integrated Pathogenetic Model of Primary Biliary Cholangitis

  2025cites this paper
• Antioxidant Activity and Anti-Inflammatory Effect of Blood Orange By-Products in Treated HT-29 and Caco-2 Colorectal Cancer Cell Lines

  2025cites this paper
• CAR-T cell therapy: A therapeutic strategy for cancer treatment.

  2025cites this paper
• Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches

  2025cites this paper
• Identification and validation of mitophagy-related genes in acute myocardial infarction and ischemic cardiomyopathy and study of immune mechanisms across different risk groups

  2025cites this paper
• Targeting the TGF-β signaling pathway: an updated patent review (2021–present)

  2024cites this paper
• Engineered Platelets for Cancer Therapy

  2024cites this paper
• Reduced estrogen signaling contributes to bone loss and cardiac dysfunction in interleukin‐10 knockout mice

  2024cites this paper
• Biochemical study of ZNF76 rs10947540 and SCUBE3 rs1888822 single nucleotide polymorphisms in the Egyptian patients with systemic lupus Erythematosus

  2024cites this paper
• Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities

  2024cites this paper
• Coronary artery bypass grafting (CABG) induces pro-inflammatory and immunomodulatory phenotype of platelets in the absence of a pro-aggregatory state.

  2024cites this paper
• Up Regulation of ZNF76 rs10947540 and SCUBE3 rs1888822 Single Nucleotide Polymorphisms as a Genetic Risk Factor in Egyptian Patients with Rheumatoid Arthritis

  2024cites this paper
• Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy

  2024cites this paper
• The Relationship between HERV, Interleukin, and Transcription Factor Expression in ZIKV Infected versus Uninfected Trophoblastic Cells

  2024cites this paper
• MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function

  2024cites this paper
• Mutual regulation between glycosylation and transforming growth factor-β isoforms signaling pathway.

  2023cites this paper
• Single-cell multi-omics sequencing reveals the immunological disturbance underlying STAT3-V637M Hyper-IgE syndrome.

  2023cites this paper
• Shaping Heterogeneity of Naive CD8+ T Cell Pools

  2023cites this paper
• Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway

  2023cites this paper
• Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes.

  2023cites this paper
• The hypoxic tissue microenvironment as a driver of mucosal inflammatory resolution

  2023cites this paper
• Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAE

  2023cites this paper
• Cardiomyocyte-Restricted Expression of IL11 Causes Cardiac Fibrosis, Inflammation, and Dysfunction

  2023cites this paper
• TGFβ and the Tumor Microenvironment in Colorectal Cancer

  2023cites this paper
• Animal models of primary biliary cholangitis: status and challenges

  2023cites this paper
• Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities

  2023cites this paper
• Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment

  2023cites this paper
• Smad7 as a positive regulator of intestinal inflammatory diseases

  2023cites this paper
• IL-17A expression by both T cells and non-T cells contribute to HSV-IL-2-induced CNS demyelination

  2023cites this paper
• Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size

  2023cites this paper
• Engineering tumor stromal mechanics for improved T cell therapy.

  2022cites this paper
• Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?

  2022cites this paper
• Transforming growth factor-β in myocardial disease

  2022cites this paper
• Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.

  2022cites this paper
• Limitations of Adaptive Immune System in Solid Tumours

  2022cites this paper
• The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis

  2022cites this paper
• Cytokines as an important player in the context of CAR-T cell therapy for cancer: Their role in tumor immunomodulation, manufacture, and clinical implications

  2022cites this paper
• TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells

  2022cites this paper
• Regulatory T cells in inflammation and resolution of acute lung injury

  2022cites this paper
• TGF-β1 suppresses the T-cell response in teleost fish by initiating Smad3- and Foxp3-mediated transcriptional networks

  2022cites this paper
• Dominant negative TGF-β receptor type II in T lymphocytes promotes anti-tumor immunity by modulating T cell subsets and enhancing CTL responses.

  2022cites this paper
• Bone Morphogenetic Proteins Shape Treg Cells

  2022cites this paper
• Impact of Manufacturing Procedures on CAR T Cell Functionality

  2022cites this paper
• Single cell genome sequencing of laboratory mouse microbiota improves taxonomic and functional resolution of this model microbial community

  2021cites this paper
• PAX6-positive microglia evolve locally in hiPSC-derived ocular organoids

  2021cites this paper
• Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.

  2021cites this paper
• Overcoming TGFβ-mediated immune evasion in cancer

  2021cites this paper
• Transforming Growth Factor Beta Suppression of CD8+ T Cell Proliferation

  2021cites this paper
• TGF-beta signaling in cancer radiotherapy.

  2021cites this paper
• Induction of IL-22-Producing CD4+ T Cells by Segmented Filamentous Bacteria Independent of Classical Th17 Cells

  2021cites this paper
• TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis

  2021cites this paper
• Prostaglandin E2 directly inhibits the conversion of inducible regulatory T cells through EP2 and EP4 receptors via antagonizing TGF‐β signalling

  2021cites this paper
• Self-driving armored CAR-T cells overcome suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models.

  2021cites this paper
• Prostaglandin E2 directly inhibits the conversion of inducible regulatory T cells through EP2 and EP4 receptors via antagonizing TGF-β signalling

  2021cites this paper
• TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer

  2021cites this paper
• SMAD4 governs a feedforward regulation of the TGF-β-effects in CD8 T cells that contributes to preventing chronic intestinal inflammation

  2021cites this paper
• TGF‐β superfamily co‐receptors in cancer

  2021cites this paper
• Genetic and biological hallmarks of colorectal cancer

  2021cites this paper
• Novel therapies emerging in oncology to target the TGF-β pathway

  2021cites this paper
• Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3+ Tregs

  2021cites this paper
• Platelet-Mediated Protection of Cancer Cells From Immune Surveillance – Possible Implications for Cancer Immunotherapy

  2021cites this paper
• Intestinal Regulatory T Cells.

  2021cites this paper
• The pathogenesis, models and therapeutic advances of primary biliary cholangitis.

  2021cites this paper
• Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery

  2021cites this paper
• New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation

  2021cites this paper
• High Smad7 in the early post-operative recurrence of Crohn’s disease

  2020cites this paper
• Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey

  2020cites this paper
• Immunosuppressive and metabolic agents that influence allo‐ and xenograft survival by in vivo expansion of T regulatory cells

  2020cites this paper
• Biphasic changes in TGF-β1 signaling drive NSAID-induced multi-organ damage.

  2020cites this paper
• Nuclear factor‐κB in rheumatoid arthritis

  2020cites this paper
• Exploring Additional Valuable Information From Single-Cell RNA-Seq Data

  2020cites this paper
• Effects of mineral methionine hydroxy analog chelate in sow diets on epigenetic modification and growth of progeny

  2020cites this paper
• Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.

  2020cites this paper
• Combination of C-C chemokine receptor 8 and dominant-negative TGF-β-receptor 2 expression in T cells for adoptive T cell therapy of solid cancer

  2020cites this paper
• TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking

  2020cites this paper
• The role of transforming growth factor‐beta in immune suppression and chronic inflammation of squamous cell carcinomas

  2020cites this paper
• The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis

  2020cites this paper
• VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance

  2020cites this paper
• Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS

  2020cites this paper
• IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model

  2020cites this paper
• Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling

  2020cites this paper
• Transcriptome analysis and identification of age-associated fertility decreased genes in hen uterovaginal junction

  2020cites this paper
• E3 ubiquitin ligase Casitas B lineage lymphoma‐b and its potential therapeutic implications for immunotherapy

  2020cites this paper
• Mechanisms of Immunosuppression in Colorectal Cancer

  2020cites this paper
• Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity.

  2020cites this paper
• TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases.

  2020cites this paper
• From Fatty Hepatocytes to Impaired Bile Flow: Matching Model Systems for Liver Biology and Disease.

  2020cites this paper
• Structural sequencing and anti-inflammatory, anti-lung cancer activities of 1,4-α/β-sulfomalonoglucan in Antrodia cinnamomea.

  2020cites this paper
• SCUBE3 Is Likely a Susceptibility Gene for Systemic Lupus Erythematosus for Chinese Populations

  2020cites this paper
• Targeting anti-fibrotic pathways in Crohn's disease - The final frontier?

  2019cites this paper
• Silence of TGF-β1 gene expression reduces prrsv replication and potentiates immunity of immune cells of tibetan pig

  2019cites this paper
• Current advances in multiple sclerosis immunopathology

  2019cites this paper
• The Role of the TGF-β Superfamily in Myocardial Infarction

  2019cites this paper
• Heligmosomoides polygyrus bakeri Infection Decreases Smad7 Expression in Intestinal CD4+ T Cells, Which Allows TGF-β to Induce IL-10–Producing Regulatory T Cells That Block Colitis

  2019cites this paper
• Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cells

  2019cites this paper
• Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells

  2019cites this paper
• T-cells "à la CAR-T(e)" - Genetically engineering T-cell response against cancer.

  2019cites this paper